Thomas Mandrup‐Poulsen

23.6k total citations · 4 hit papers
283 papers, 17.3k citations indexed

About

Thomas Mandrup‐Poulsen is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas Mandrup‐Poulsen has authored 283 papers receiving a total of 17.3k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Surgery, 139 papers in Genetics and 111 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas Mandrup‐Poulsen's work include Pancreatic function and diabetes (142 papers), Diabetes and associated disorders (129 papers) and Diabetes Management and Research (51 papers). Thomas Mandrup‐Poulsen is often cited by papers focused on Pancreatic function and diabetes (142 papers), Diabetes and associated disorders (129 papers) and Diabetes Management and Research (51 papers). Thomas Mandrup‐Poulsen collaborates with scholars based in Denmark, Sweden and United States. Thomas Mandrup‐Poulsen's co-authors include Marc Y. Donath, Jørn Nerup, Décio L. Eizirik, Charles A. Dinarello, Hubert Kolb, Claus M. Larsen, Klaus Bendtzen, Joachim Størling, Jens Høiriis Nielsen and Nils Billestrup and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Thomas Mandrup‐Poulsen

280 papers receiving 16.8k citations

Hit Papers

Interleukin-1–Receptor Antagonist in Typ... 1986 2026 1999 2012 2007 2001 1986 2019 400 800 1.2k

Peers

Thomas Mandrup‐Poulsen
Marc Y. Donath Switzerland
Frans Schuit Belgium
Philip W. Shaul United States
Miriam Cnop Belgium
Myung‐Shik Lee South Korea
Marc Y. Donath Switzerland
Thomas Mandrup‐Poulsen
Citations per year, relative to Thomas Mandrup‐Poulsen Thomas Mandrup‐Poulsen (= 1×) peers Marc Y. Donath

Countries citing papers authored by Thomas Mandrup‐Poulsen

Since Specialization
Citations

This map shows the geographic impact of Thomas Mandrup‐Poulsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mandrup‐Poulsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mandrup‐Poulsen more than expected).

Fields of papers citing papers by Thomas Mandrup‐Poulsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Mandrup‐Poulsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mandrup‐Poulsen. The network helps show where Thomas Mandrup‐Poulsen may publish in the future.

Co-authorship network of co-authors of Thomas Mandrup‐Poulsen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Mandrup‐Poulsen. A scholar is included among the top collaborators of Thomas Mandrup‐Poulsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Mandrup‐Poulsen. Thomas Mandrup‐Poulsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levine, Daniel C., et al.. (2025). Unsaturated fat alters clock phosphorylation to align rhythms to the season in mice. Science. 390(6771). eadp3065–eadp3065.
2.
Ghiasi, Seyed Mojtaba, Piero Marchetti, Lorenzo Piemonti, et al.. (2024). Proinflammatory cytokines suppress nonsense-mediated RNA decay to impair regulated transcript isoform processing in pancreatic β cells. Frontiers in Endocrinology. 15. 1359147–1359147. 2 indexed citations
3.
Arora, Tulika, Juliana Assis Geraldo, Mark K. Nøhr, et al.. (2024). Sexual Dimorphism in the Immunometabolic Role of Gpr183 in Mice. Journal of the Endocrine Society. 8(12). bvae188–bvae188. 1 indexed citations
4.
Brazhe, Nadezda A., Olga Sosnovtseva, Claus Desler, et al.. (2024). Oxidized guanosines induce mitochondrial dysfunction and loss of viability in β-cells. SHILAP Revista de lepidopterología. 8. 100022–100022. 1 indexed citations
5.
Novotny, Guy Wayne, et al.. (2023). Obesity‐induced changes in gene expression in feline adipose and skeletal muscle tissue. Journal of Animal Physiology and Animal Nutrition. 107(5). 1262–1278. 2 indexed citations
6.
Bartlett, Stacey, Helle Bielefeldt‐Ohmann, Buddhika J. Arachchige, et al.. (2022). A Blunted GPR183/Oxysterol Axis During Dysglycemia Results in Delayed Recruitment of Macrophages to the Lung During Mycobacterium tuberculosis Infection. The Journal of Infectious Diseases. 225(12). 2219–2228. 17 indexed citations
7.
Simon, Christian, Marie Balslev Backe, Mattias Salling Dahllöf, et al.. (2020). Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells. International Journal of Molecular Sciences. 21(21). 8016–8016. 6 indexed citations
9.
Novotny, Guy Wayne, et al.. (2014). Obesity related differences in MCP-1 and adiponectin expression in subcutaneous adipose tissue in cats.. Research at the University of Copenhagen (University of Copenhagen). 1 indexed citations
10.
Dahllöf, Mattias Salling, et al.. (2014). HDAC Inhibitor-Mediated Beta-Cell Protection Against Cytokine-Induced Toxicity Is STAT1 Tyr701 Phosphorylation Independent. Journal of Interferon & Cytokine Research. 35(1). 63–70. 11 indexed citations
11.
Cavelti‐Weder, Claudia, Cornelia Keller, Marc Stahel, et al.. (2012). Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes. Diabetes Care. 35(8). 1654–1662. 229 indexed citations
12.
Pozzilli, Paolo, Nóra Hosszúfalusi, Angelo Lauria, et al.. (2011). Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres. Diabetologia. 54. 1 indexed citations
13.
Lewis, Eli C., Joachim Størling, Sif G. Rønn, et al.. (2011). The Oral Histone Deacetylase Inhibitor ITF2357 Reduces Cytokines and Protects Islet β Cells In Vivo and In Vitro. Molecular Medicine. 17(5-6). 369–377. 87 indexed citations
14.
Mandrup‐Poulsen, Thomas, et al.. (2009). The anti‐interleukin‐1 in type 1 diabetes action trial—background and rationale. Diabetes/Metabolism Research and Reviews. 25(4). 321–324. 28 indexed citations
15.
Berchtold, Lukas Adrian, Claus M. Larsen, Allan Vaag, et al.. (2009). IL-1 receptor antagonism and muscle gene expression in patients with type 2 diabetes. European Cytokine Network. 20(2). 81–87. 10 indexed citations
16.
Rønn, Sif G., Christine Bruun, Claus M. Larsen, et al.. (2008). IL-1β-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells. Diabetologia. 52(2). 281–288. 20 indexed citations
17.
Pociot, Flemming, Søren K. Paulsen, K. Borch‐Johnsen, et al.. (2006). Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance. Genes and Immunity. 7(4). 316–321. 22 indexed citations
18.
O’Brien, Timothy, Allan E. Karlsen, Henrik U. Andersen, Thomas Mandrup‐Poulsen, & Jørn Nerup. (1999). Absence of toxicity associated with adenoviral-mediated transfer of the β-galactosidase reporter gene to neonatal rat islets in vitro. Diabetes Research and Clinical Practice. 44(3). 157–163. 5 indexed citations
19.
Mauricio, Dı́dac, Henrik U. Andersen, Claus M. Larsen, et al.. (1997). DEXAMETHASONE PREVENTS INTERLEUKIN-1β-MEDIATED INHIBITION OF RAT ISLET INSULIN SECRETION WITHOUT DECREASING NITRIC OXIDE PRODUCTION. Cytokine. 9(8). 563–569. 8 indexed citations
20.
Bækkeskov, Steinunn, Maria A. Landin, Jørgen Kvist Kristensen, et al.. (1987). Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.. Journal of Clinical Investigation. 79(3). 926–934. 262 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026